News Home

What is the Market's View on Intra-Cellular Therapies Inc (ITCI) Stock's Price and Volume Trends

Monday, February 08, 2021 01:21 PM | InvestorsObserver Analysts
What is the Market's View on Intra-Cellular Therapies Inc (ITCI) Stock's Price and Volume Trends

The market has been high on Intra-Cellular Therapies Inc (ITCI) stock recently. ITCI gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Intra-Cellular Therapies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ITCI!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With ITCI Stock Today?

Intra-Cellular Therapies Inc (ITCI) stock is trading at $37.29 as of 1:19 PM on Monday, Feb 8, a rise of $1.53, or 4.28% from the previous closing price of $35.76. The stock has traded between $35.54 and $37.60 so far today. Volume today is low. So far 437,182 shares have traded compared to average volume of 667,920 shares.

To see InvestorsObserver's Sentiment Score for Intra-Cellular Therapies Inc click here.

More About Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Click Here to get the full Stock Score Report on Intra-Cellular Therapies Inc (ITCI) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App